Medicare

CMS Expands Botulinum Toxin Prior Authorization

Eight more botulinum toxin codes enter Medicare's hospital outpatient prior authorization program July 1, 2027. OT teams should prepare referral and scheduling handoffs.

CMSHospital outpatient OTPrior authorizationBotulinum toxinNeurorehabilitation
Conceptual image of rehabilitation staff reviewing paperwork and a computer at a clinic desk
Conceptual clinic image; it does not depict CMS staff, an identified practice, or actual patient records.

CMS's November 4 final outpatient rule, November 6 Federal Register publication, and hospital outpatient prior authorization guidance

An injection appointment can anchor a patient's rehabilitation calendar. CMS has now finalized a change that hospital outpatient OT teams should build into that planning: eight additional botulinum toxin codes will require prior authorization for service dates beginning July 1, 2027. The expansion is part of the outpatient payment rule issued November 4 and published November 6.

In brief

  • The added codes begin July 1, 2027, six months after the rule's general effective date.
  • Table 102 includes limb procedures 64642 and 64644, alongside other injection procedures and drug code J0589.
  • This expansion concerns listed hospital outpatient injection services; it adds no OT treatment codes.

Match the code and the setting

The complete additions are 64611, 64616, 64617, 64642, 64644, 64646, 64647, and J0589. Table 102 on Federal Register page 70712 gives the descriptions. These entries comprise seven procedure codes and one drug code.

For OT services coordinating care with an injecting clinician, start by asking which codes the hospital bills and whether the hospital outpatient program applies. Keep the injection authorization and any separate therapy authorization visible in the scheduling record. An approval for one service should never be assumed to cover the other.

Allow time for review

CMS's program sends documentation for review before the covered service takes place. It checks existing coverage, coding, and payment requirements. The agency says it will provide implementation education ahead of July and update its operational resources.

In the final rule, CMS describes standard review within seven calendar days and expedited review within two business days when delay could seriously jeopardize life, health, or the ability to regain maximum function. Qualifying providers may have an exemption. These provisions call for checking the hospital's status and current contractor instructions; they cannot promise an appointment date.

Give a changed appointment somewhere to go

A practical preparation exercise is to trace a hypothetical postponed injection through the rehab schedule. Name the person who tells the OT, the person who contacts the patient, and the clinician who decides whether the therapy plan needs revision. Those handoffs are local planning recommendations.

The OT's contribution can stay close to daily life. Record the activity the patient wants to manage, the assistance currently needed, and the functional change being pursued. Where relevant, that might mean describing how a hand position affects washing the palm or getting an arm through a sleeve. The injecting clinician and authorization team can determine which records support the request.

Before July, compare the team's written workflow with a real scheduling example. A pending request should have an owner and a next review date, so the patient is not left carrying messages between departments.

Decision use

How to use this analysis

Read the source documents and linked resources to check which findings apply to your situation.

Explore OT practice settings1

Compare the work and career questions across hospital and outpatient practice.

Open next step